Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bastide Le Confort MedicalLTS:0IP1 -1.09%70 EV-to-OCF is 3.94 as of Aug. 15, 2026, which is 52% below its 10-year median of 8.26. GuruFocus rates LTS:0IP1 with a GF Score™ of 70/100 and a GF Value™ of €26.01 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 118 Medical Distribution companies, Bastide Le Confort Medical ranks better than 61.02% on this metric.
The historical rank and industry rank for Bastide Le Confort Medical's EV-to-OCF or its related term are showing as below:
LTS:0IP1'
s EV-to-OCF Range Over the Past 10 Years
Min: 3.95 Med: 8.26 Max: 21.33
Current: 3.95
During the past 13 years, the highest EV-to-OCF of Bastide Le Confort Medical was 21.33. The lowest was 3.95. And the median was 8.26.
LTS:0IP1's EV-to-OCF is ranked better than 61.02% of 118
companies
in the Medical Distribution industry
Industry Median: 7.475
vs LTS:0IP1: 3.95
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Bastide Le Confort Medical (LTS:0IP1) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Bastide Le Confort Medical's PE Ratio (TTM) for today is calculated as:
Bastide Le Confort Medical's share price for today is €22.60.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Bastide Le Confort Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €3.710.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Bastide Le Confort Medical EV-to-OCF Related Terms
Bastide Le Confort Medical EV-to-OCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Bastide Le Confort Medical's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bastide Le Confort Medical EV-to-OCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Bastide Le Confort Medical's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Bastide Le Confort Medical's EV-to-OCF falls into.
Bastide Le Confort Medical's current Enterprise Value is €462.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Bastide Le Confort Medical's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was €117.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bastide Le Confort Medical (LTS:0IP1) has a EV-to-OCF of 3.94 as of Aug. 15, 2026. This is 52% below median its historical median of 8.26. Over the past decade, Bastide Le Confort Medical's EV-to-OCF has ranged from 3.95 to 21.33. According to the industry distribution chart, Bastide Le Confort Medical ranks #46 out of 118 companies in the Medical Distribution industry, placing it in the top 39%.
Is Bastide Le Confort Medical's EV-to-OCF too high?
Bastide Le Confort Medical's current EV-to-OCF of 3.94 is 52% below median its 10-year median of 8.26. Over the past 10 years, this metric has ranged from a low of 3.95 to a high of 21.33. The Medical Distribution industry median EV-to-OCF is 7.48. Bastide Le Confort Medical's value of 3.94 is 47.3% below this industry median. Based on the distribution chart, Bastide Le Confort Medical ranks #46 out of 118 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Bastide Le Confort Medical has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bastide Le Confort Medical's EV-to-OCF compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Bastide Le Confort Medical ranks #46 out of 118 companies for EV-to-OCF. This puts Bastide Le Confort Medical in the upper half of its industry. The industry median EV-to-OCF is 7.48. Bastide Le Confort Medical's value of 3.94 is 47.3% below this benchmark. Historically, Bastide Le Confort Medical's own EV-to-OCF has ranged from 3.95 to 21.33 over the past decade. While the company's 10-year median is 8.26 vs. the industry median of 7.48, Bastide Le Confort Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Distribution company?
The median EV-to-OCF among Medical Distribution companies is 7.48, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bastide Le Confort Medical's current EV-to-OCF of 3.94 is 47.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median EV-to-OCF is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bastide Le Confort Medical's current EV-to-OCF is 3.94, which is 52% below median its own 10-year median of 8.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bastide Le Confort Medical stock overvalued right now?
Based on GuruFocus' analysis, Bastide Le Confort Medical (LTS:0IP1) is currently considered Modestly Undervalued. The stock's GF Value™ is €26.01, compared to a current price of €22.60 — trading 13.1% below its estimated fair value. The current EV-to-OCF is 3.94, which is 52% below median its 10-year median of 8.26 and 47.3% below the Medical Distribution industry median of 7.48. Bastide Le Confort Medical's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Bastide Le Confort Medical (LTS:0IP1), the current EV-to-OCF is 3.94 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bastide Le Confort Medical (LTS:0IP1) Overvalued in 2026?
Based on GuruFocus' analysis, Bastide Le Confort Medical stock appears to be undervalued.
The current stock price of €22.60 is trading 13.1% below its estimated GF Value™ of €26.01.
GuruFocus considers Bastide Le Confort Medical to be Modestly Undervalued.
Key valuation signals for LTS:0IP1:
EV-to-OCF: 3.94 (52% below median its 10-year median of 8.26)
GF Value™: €26.01 vs. price of €22.60 (13.1% below fair value)
Industry Position: 47.3% below the Medical Distribution median (#46 of 118)
No single metric tells the full story. See the LTS:0IP1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bastide Le Confort Medical SA is a France-based company that is engaged in the sale and rental of medical supplies and equipment for the home care of the elderly, sick and disabled. The company provides care equipment, such as hospital beds, personal assistance products, nutrition, insulin pumps, and syringe-drivers.
70GF Score
Get the complete analysis for LTS:0IP1
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0IP1 has been successfully added to your 
